These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7875170)

  • 41. Assessment of tumour necrosis and detection of mediastinal lymph node metastasis in bronchial carcinoma with technetium-99m sestamibi imaging: comparison with CT scan.
    Aktolun C; Bayhan H; Pabuccu Y; Bilgic H; Acar H; Koylu R
    Eur J Nucl Med; 1994 Sep; 21(9):973-9. PubMed ID: 7995292
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A metastatic neuroendocrine anaplastic small cell tumor in a patient with multiple endocrine neoplasia type 1 syndrome. Assessment of disease status and response to doxorubicin, cyclophosphamide, etoposide chemotherapy through scintigraphic imaging with 111In-pentetreotide.
    O'Byrne KJ; Goggins MG; McDonald GS; Daly PA; Kelleher DP; Weir DG
    Cancer; 1994 Oct; 74(8):2374-8. PubMed ID: 7922988
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 111In-octreotide scintigraphy in small cell lung cancer.
    Semprebene A; Ferraironi A; Franciotti G; Venturo I; Giunta S; Lopez M; Maini CL
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):108-10. PubMed ID: 9002764
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnostic accuracy of virtual 18F-FDG PET/CT bronchoscopy for the detection of lymph node metastases in non-small cell lung cancer patients.
    Herbrik M; Treffert J; Geiger B; Riegger C; Hartung V; Rosenbaum-Krumme SJ; Forsting M; Antoch G; Heusner TA
    J Nucl Med; 2011 Oct; 52(10):1520-5. PubMed ID: 21908390
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The scintigraphy of somatostatin receptors in the carcinoid tumor].
    Banzo J; Abós MD; Prats E; Delgado M; Razola P; García S; Gomollón F; García F
    Rev Esp Med Nucl; 2001 Feb; 20(1):11-8. PubMed ID: 11181324
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Imaging of somatostatin receptors by indium-111-pentetreotide correlates with quantitative determination of somatostatin receptor type 2 gene expression in neuroblastoma tumors.
    Briganti V; Sestini R; Orlando C; Bernini G; La Cava G; Tamburini A; Raggi CC; Serio M; Maggi M
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2385-91. PubMed ID: 9815638
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Imaging lung cancer with radiolabeled antibodies.
    Breitz HB; Sullivan K; Nelp WB
    Semin Nucl Med; 1993 Apr; 23(2):127-32. PubMed ID: 8390098
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The place of computed tomography in the staging of bronchial carcinoma. A retrospective study].
    Madeja C; Hieckel HG; Lüning M
    Rofo; 1992 Jun; 156(6):540-4. PubMed ID: 1319770
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Indium-111-pentetreotide in Graves' disease.
    Kahaly G; Görges R; Diaz M; Hommel G; Bockisch A
    J Nucl Med; 1998 Mar; 39(3):533-6. PubMed ID: 9529305
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lymph node metastasis diagnosis using positron emission tomography with 2-[18F] fluoro-2-deoxy-D-glucose as a tracer and computed tomography in surgical cases of non-small cell lung cancer.
    Ose N; Sawabata N; Minami M; Inoue M; Shintani Y; Kadota Y; Okumura M
    Eur J Cardiothorac Surg; 2012 Jul; 42(1):89-92. PubMed ID: 22290887
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of iodine-123-Tyr-3-octreotide scintigraphy in the staging of small-cell lung cancer.
    Leitha T; Meghdadi S; Studnicka M; Wolzt M; Marosi C; Angelberger P; Neumann M; Schlick W; Kletter K; Dudczak R
    J Nucl Med; 1993 Sep; 34(9):1397-402. PubMed ID: 8394882
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative SPECT findings of Tc-99m depreotide, Tc-99m tetrofosmin, and Tl-201 chloride for bronchogenic carcinoma.
    Shih WJ; Bensadoun ES; Hirschowitz E; Kieffer V; Gross K
    Clin Nucl Med; 2002 Sep; 27(9):676-9. PubMed ID: 12192295
    [No Abstract]   [Full Text] [Related]  

  • 53. SPECT improves accuracy of somatostatin receptor scintigraphy in abdominal carcinoid tumors.
    Schillaci O; Scopinaro F; Angeletti S; Tavolaro R; Danieli R; Annibale B; Gualdi G; Delle Fave G
    J Nucl Med; 1996 Sep; 37(9):1452-6. PubMed ID: 8790191
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Somatostatin receptor scintigraphy in the initial staging of low-grade non-Hodgkin's lymphomas.
    Lugtenburg PJ; Löwenberg B; Valkema R; Oei HY; Lamberts SW; Eijkemans MJ; van Putten WL; Krenning EP
    J Nucl Med; 2001 Feb; 42(2):222-9. PubMed ID: 11216520
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Indium-111-Octreotide scintigraphy in differentiated thyroid carcinoma metastases that do not respond to treatment with high-dose I-131.
    Stokkel MP; Reigman HI; Verkooijen RB; Smit JW
    J Cancer Res Clin Oncol; 2003 May; 129(5):287-94. PubMed ID: 12750997
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cost-effectiveness analysis of somatostatin receptor scintigraphy.
    Kwekkeboom DJ; Lamberts SW; Habbema JD; Krenning EP
    J Nucl Med; 1996 Jun; 37(6):886-92. PubMed ID: 8683305
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tc-99m depreotide SPECT/CT for lymph node staging of non-small-cell lung cancer.
    Apostolopoulos DJ; Koletsis EN; Spyridonidis T; Paschali A; Papandrianos N; Stamou E; Vassilakos PJ; Dougenis D
    Ann Nucl Med; 2014 Jun; 28(5):463-71. PubMed ID: 24668640
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Somatostatin receptor imaging in small cell lung cancer.
    Berenger N; Moretti JL; Boaziz C; Vigneron N; Morere JF; Breau JL
    Eur J Cancer; 1996 Jul; 32A(8):1429-31. PubMed ID: 8869110
    [TBL] [Abstract][Full Text] [Related]  

  • 59. False-positivity of mediastinal lymph nodes has negative effect on survival in potentially resectable non-small cell lung cancer.
    Iskender I; Kadioglu SZ; Cosgun T; Kapicibasi HO; Sagiroglu G; Kosar A; Kir A
    Eur J Cardiothorac Surg; 2012 Apr; 41(4):874-9. PubMed ID: 22423060
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of whole-body FDG-PET to bone scan for detection of bone metastases in patients with a new diagnosis of lung cancer.
    Cheran SK; Herndon JE; Patz EF
    Lung Cancer; 2004 Jun; 44(3):317-25. PubMed ID: 15140545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.